Partner With Us
Demonstrate Your Expertise to Precision Oncology Trailblazers In-Person this November
The Liquid Biopsy Surveillance & Early Detection Summit is your prime platform to network and connect with precision oncology decision makers actively looking to discover & learn about the latest in non-invasive testing technology.
Take this unique opportunity to showcase your novel tools and technologies to a community eager to establish the industry applications of early detection and patient monitoring assays, and become the partner of choice in an industry poised for exponential growth in 2023.
Due to the commercial and marketing successes of events in the Biomarkers & Diagnostics event series have historically provided, we’re already running low on partnership opportunities.
“Lots of great speakers from across industry and academia who shared insights on partnership and opportunities.” Illumina, 6th Liquid Biopsy for Precision Oncology Summit
Our biopharma & academic audience are looking for help in:
Liquid Biopsy Assay Development
providing sensitive surveillance and early detection possibilities
CRO Partnerships
supporting clinical planning for fast-tracked regulatory filing
Reference Laboratories
accelerating assay validation
NGS & Sequencing Providers
enabling informed clinical decision making
Get in Touch for a Consultation Today:
